BioNTech 表示与辉瑞的合作保持不变路透法兰克福11月13日 - BioNTech 22UAy.DE周四在被问及对辉瑞正在寻求出售其在这家德国生物技术公司的股份的报导发表评论时说,它与辉瑞PFE.N的合作没有改变。
一位发言人在一份声明中说:"我们继续保持着密切而牢固的合作关系,"他补充说,BioNTech公司不会对辉瑞公司的任何资本市场活动发表评论。
(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)
At the request of the copyright holder, you need to log in to view this content
LOGIN / SIGN UPDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.